What is your current position?
I am a group leader focused on tissue regeneration and the resolution of inflammation at the Center for Regenerative Therapies Dresden (CRTD), part of Technische Universität Dresden (TUD). I am actively involved in teaching within the Master’s program Regenerative Biology and Medicine.
Within the Transregio CRC 369 “DIONE – Degeneration of Bone due to Inflammation,” I lead project B03, which investigates the protective role of eosinophils in bone loss associated with inflammatory arthritis.
What is your main research focus?
My research focuses on the often overlooked homeostatic and regulatory roles of eosinophils, exploring how these cells, traditionally viewed as pro-inflammatory effectors, also contribute to the resolution of inflammation and tissue regeneration across multiple organs. Building on our discoveries of regulatory eosinophil populations in joints and bone marrow, we investigate how tissue microenvironments shape eosinophil phenotypes at metabolic, epigenetic, and proteomic levels. Our long-term goal is to reprogram eosinophils toward a tissue-protective, pro-resolving state to improve outcomes in chronic inflammatory diseases.
What does your typical workday look like?
I recently launched my own research group in Dresden and the first months have been all about building a lab from the ground up and getting our science rolling. These days, my routine is a mix of mentoring amazing PhD, master’s, and bachelor’s students, staying hands-on at the bench, analyzing data, leading lab meetings, collaborating with clinical partners, and advancing grants and publications. I also teach in the Master’s program Regenerative Biology and Medicine, where I get to share why immunology is such a powerful field and how it shapes our fight against chronic inflammatory diseases.
